Theravance Biopharma, Inc. (TBPH)
17.07
+0.04
(+0.23%)
USD |
NASDAQ |
Sep 02, 16:00
17.07
0.00 (0.00%)
After-Hours: 20:00
Theravance Biopharma Net Income (TTM) : 53.81M for June 30, 2026
Net Income (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Net Income (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 53.81M |
| March 31, 2026 | 114.54M |
| December 31, 2025 | 105.90M |
| September 30, 2025 | 29.34M |
| June 30, 2025 | 13.03M |
| March 31, 2025 | -58.33M |
| December 31, 2024 | -56.42M |
| September 30, 2024 | -49.40M |
| June 30, 2024 | -45.65M |
| March 31, 2024 | -44.77M |
| December 31, 2023 | -55.19M |
| September 30, 2023 | -60.94M |
| June 30, 2023 | -68.01M |
| March 31, 2023 | -75.16M |
| December 31, 2022 | -93.33M |
| September 30, 2022 | -136.89M |
| June 30, 2022 | -176.78M |
| March 31, 2022 | -206.39M |
| December 31, 2021 | -245.81M |
| September 30, 2021 | -246.43M |
| June 30, 2021 | -264.16M |
| March 31, 2021 | -274.64M |
| December 31, 2020 | -278.02M |
| September 30, 2020 | -285.19M |
| June 30, 2020 | -269.98M |
| Date | Value |
|---|---|
| March 31, 2020 | -246.93M |
| December 31, 2019 | -236.46M |
| September 30, 2019 | -221.04M |
| June 30, 2019 | -222.04M |
| March 31, 2019 | -223.02M |
| December 31, 2018 | -215.52M |
| September 30, 2018 | -252.26M |
| June 30, 2018 | -259.70M |
| March 31, 2018 | -285.17M |
| December 31, 2017 | -285.40M |
| September 30, 2017 | -265.82M |
| June 30, 2017 | -232.90M |
| March 31, 2017 | -213.84M |
| December 31, 2016 | -190.67M |
| September 30, 2016 | -168.16M |
| June 30, 2016 | -181.52M |
| March 31, 2016 | -181.90M |
| December 31, 2015 | -182.22M |
| September 30, 2015 | -201.70M |
| June 30, 2015 | -208.88M |
| March 31, 2015 | -219.49M |
| December 31, 2014 | -237.04M |
| September 30, 2014 | -216.81M |
| June 30, 2014 | -203.39M |
| March 31, 2014 | -184.13M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (TTM) Benchmarks
| Zymeworks, Inc. | -149.99M |
| Viatris, Inc. | -410.70M |
| Ocular Therapeutix, Inc. | -301.45M |
| ANI Pharmaceuticals, Inc. | 99.95M |
| Corcept Therapeutics, Inc. | 54.20M |